Foundation Resource Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.53M Buy
177,838
+3,712
+2% +$159K 0.99% 37
2026
Q1
$6.4M Buy
174,126
+5,312
+3% +$252K 0.72% 40
2025
Q4
$8.59M Buy
168,814
+1,048
+0.6% +$53.6K 1.15% 28
2025
Q3
$9.31M Buy
+167,766
New +$9.82M 1.34% 26

Other funds holding NVO

Foundation Resource Management's NVO Position: Q2 2026 in Review

Foundation Resource Management increased its Novo Nordisk (NVO) stake by 2.1% in Q2 2026, buying an estimated $159K and bringing the position to 177,838 shares worth $8.53M. The position accounts for 0.99% of the portfolio, ranked #37.

Foundation Resource Management first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.31M in Q3 2025. 344 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Foundation Resource Management held 177,838 shares of Novo Nordisk worth $8.53M as of Q2 2026.
  • Foundation Resource Management bought 3,712 Novo Nordisk shares in Q2 2026, an estimated $159K.
  • Novo Nordisk made up 0.99% of Foundation Resource Management's portfolio in Q2 2026, its #37 holding.
  • Foundation Resource Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • Foundation Resource Management's Novo Nordisk position peaked at $9.31M in Q3 2025.
  • 344 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Foundation Resource Management's 13F filing for Q2 2026, filed 21 Jul 2026.